JUDITH CASSIDY: Open Payments
NPI 1790365849 · MAYS LANDING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,897 in 82 payments from 8 companies in 2025. Trend: 2023 $662 · 2024 $1,641 · 2025 $1,897
Food & beverage: $1,799Education: $98
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $389 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $343 |
| E.R. Squibb & Sons, L.L.C. | 15 | $316 |
| Teva Pharmaceuticals USA, Inc. | 12 | $265 |
| Otsuka America Pharmaceutical, Inc. | 8 | $248 |
| Alkermes, Inc. | 14 | $209 |
| Janssen Pharmaceuticals, Inc | 4 | $72 |
| Lundbeck LLC | 3 | $55 |
Products named: INGREZZA, CAPLYTA, COBENFY, REXULTI, ARISTADA, UZEDY, ABILIFY ASIMTUFII, VIVITROL.
Industry payments across NJ — which companies pay providers there.
